BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival

Haguet, Hélène;Douxfils, Jonathan;Mullier, François;Chatelain, Christian;Dogné, Jean-Michel;et.al.
(2016) Belgian Haematological Society — Location: La Hulpe, Belgique (29.January.2016)

Files

No attached file found for this publication.

Details

Authors
  • Haguet, Hélène
    Author
  • Douxfils, Jonathan
    Author
  • Mullier, FrançoisUCLouvain
    Author
  • Chatelain, ChristianUCLouvain
    Author
  • Graux, CarlosUCLouvain
    Author
  • Dogné, Jean-Michel
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Haguet, H., Douxfils, J., Mullier, F., Chatelain, C., Graux, C., & Dogné, J.-M. (2016). BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival. Belgian Haematological Society, La Hulpe, Belgique. https://hdl.handle.net/2078.5/179804